Galapagos NV
GLPG
#5078
Rank
A$2.68 B
Marketcap
A$40.01
Share price
0.00%
Change (1 day)
-7.83%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2026 (TTM): A-$0.84

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is A-$0.59. In 2025 the company made an earnings per share (EPS) of A$8.25 an increase over its 2024 EPS that were of A$1.68.

EPS history for Galapagos NV from 2004 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$0.84-110.17%
2025A$8.25390.86%
2024A$1.68-67.16%
2023A$5.12-199.64%
2022A-$5.1499.03%
2021A-$2.58-68.98%
2020A-$8.32-298.06%
2019A$4.20-554.64%
2018A-$0.92-77.18%
2017A-$4.05-326.21%
2016A$1.79-134.19%
2015A-$5.24-371.34%
2014A$1.93-445.98%
2013A-$0.5632.88%
2012A-$0.42-82.07%
2011A-$2.34-817.9%
2010A$0.3312.73%
2009A$0.29-120.79%
2008A-$1.39-37.67%
2007A-$2.2339.64%
2006A-$1.6028.17%
2005A-$1.256.25%
2004A-$1.17

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.60-2,244.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.21-985.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
A$2.97-604.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.69-728.35%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$5.13-973.26%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
A$10.03-1,806.09%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
A$5.61-1,054.01%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
A-$0.88 49.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
A$1.98-436.31%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel